No Data
No Data
Express News | ARS Pharmaceuticals Shares up 4.8% Premarket as EU Regulator Recommends Approval for Co's Nasal Spray Alternative to Epipen
CHMP Endorses ARS Nasal Spray for Anaphylaxis
ARS Pharmaceuticals Gets CHMP Backing for Epinephrine Nasal Spray
By Colin Kellaher ARS Pharmaceuticals has moved a step closer to winning European approval of its proposed epinephrine nasal spray for the emergency treatment of severe allergic reaction. ARS on Fri
Express News | ARS Pharmaceuticals Inc: Eurneffy Same Data Package Under Review by FDA With a Pdufa Date of Oct 2
Express News | ARS Pharmaceuticals: After Grant of Marketing Authorization by Ec Expected in Q3, Expects Eurneffy to Be Made Available to Patients in Europe in Q4
Express News | ARS Pharmaceuticals Inc - Ec Marketing Authorization Expected in Q3 2024
No Data
Monster madness : Guessing if they can get US approval also in the fall this will be a high double digit stock.
TrytosaveabitOP Monster madness: Howdy! So depending on where it’s trading at if/when that approval come? It very well could break up passed 13+! On another note. Yes this had some decent news for today. It just didn’t get much of a PI. The overall market was in pretty bad shape though. But it did get enough of a PI to finish making a nice small double bottom on the daily. So I will be watching very closely on Monday! See if the double bottom now continues and breaks upward! BTW sorry for the late reply! But Fridays I can’t be here after about 9:30AM est! I have a previous obligation that takes me away! I try to check in through the day if time permits. Like now. I had a few minutes before I jump in the truck to head home and decided to use the few free minutes to check in! Hope you had a good day.
Monster madness : Have a great weekend, your insight is always very appreciated
TrytosaveabitOP Monster madness: Thank you! You have a great weekend as well!